Work

The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases

Year: 2009

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.109.153973

Authors: Dulce Soler, Tobias Chapman, Li-Li Yang, Tim Wyant, Robert Egan, Eric R. Fedyk

Institution: Takeda Oncology (United States)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2160619682

FWCI: 8.683

Cites: 46

Cited by: 473

Related to: 9